NDC 0074-1564

Depacon

Valproate Sodium

Depacon is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Abbvie Inc.. The primary component is Valproate Sodium.

• Product ID: 0074-1564_aff2aee6-35aa-e6ff-87e5-7d9448b70b38
• NDC: 0074-1564
• Product Type: Human Prescription Drug
• Proprietary Name: Depacon
• Generic Name: Valproate Sodium
• Dosage Form: Injection
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 1996-12-30
• Marketing End Date: 2019-11-01
• Marketing Category: NDA / NDA
• Application Number: NDA020593
• Labeler Name: AbbVie Inc.
• Substance Name: VALPROATE SODIUM
• Active Ingredient Strength: 100 mg/mL
• Pharm Classes: Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC]
• NDC Exclude Flag: N

Packaging

NDC 0074-1564-10

10 VIAL, SINGLE-DOSE in 1 CARTON (0074-1564-10) > 5 mL in 1 VIAL, SINGLE-DOSE

• Marketing Start Date: 1996-12-30
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0074-1564-10 [00074156410]

Depacon INJECTION

• Marketing Category: NDA
• Application Number: NDA020593
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 1996-12-30
• Marketing End Date: 2019-11-01

Drug Details

Active Ingredients

Ingredient	Strength
VALPROATE SODIUM	100 mg/mL

OpenFDA Data

• SPL SET ID: da030cbb-40f6-4805-9883-0d8945afbcc3
• Manufacturer:
  • AbbVie Inc.
• UNII:
  • 5VOM6GYJ0D
• RxNorm Concept Unique ID - RxCUI:
  • 1099650
  • 1099648

Pharmacological Class

• Anti-epileptic Agent [EPC]
• Decreased Central Nervous System Disorganized Electrical Activity [PE]
• Mood Stabilizer [EPC]

NDC Crossover Matching brand name "Depacon" or generic name "Valproate Sodium"

NDC	Brand Name	Generic Name
0074-1564	Depacon	Valproate Sodium
0143-9637	Valproate Sodium	Valproate Sodium
0143-9785	Valproate Sodium	Valproate Sodium
63323-494	Valproate Sodium	VALPROATE SODIUM
70860-784	Valproate Sodium	valproate sodium